| USD millions | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.9 | 10.8 | 9.8 | 8.1 | 11.2 | 11.8 | +5.7% | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 10.9 | 10.8 | 9.8 | 8.1 | 11.2 | 11.8 | +5.7% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 2.9 | 3.1 | 2.9 | 3.5 | 3.4 | 2.8 | −16.9% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 25.7 | 75.0 | 12.5 | 107.5 | 103.8 | 23.4 | −77.4% | |
| Operating income | 8.0 | 7.7 | 6.9 | 4.7 | 7.8 | 9.0 | +15.6% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | (22.8) | 78.1 | (9.6) | 110.9 | (100.3) | 26.3 | +126.2% | |
| Pre-tax income | (14.8) | 85.8 | (2.6) | 115.6 | (92.5) | 35.3 | +138.1% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | (100.3) | 26.3 | +126.2% | |
| Net income | (14.8) | 85.8 | (2.6) | 115.6 | (92.6) | 35.3 | +138.1% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.57) | 3.27 | (0.10) | 4.40 | (3.50) | 1.33 | +138.0% | |
| EPS, diluted (per share) | (0.57) | 3.27 | (0.10) | 4.40 | (3.50) | 1.33 | +138.0% | |
| EBITDA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 26.3 | — | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | — | |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | +0.0 pts | |
| Operating margin | 73.5% | 71.5% | 70.5% | 57.6% | 69.4% | 76.0% | +6.5 pts | |
| Net margin | −136.5% | 795.4% | −26.9% | 1,419.0% | −825.8% | 297.6% | +1123.4 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
